Fresh Tracks Therapeutics, Inc. announced that Aaron Fox-Collis was appointed VP of Finance & Chief Accounting Officer and principal accounting officer of the Company, effective January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9166 USD | -1.81% | +1.83% | +4.27% |
Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
+4.27% | 5.58M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- FRTX Stock
- News Fresh Tracks Therapeutics, Inc.
- Fresh Tracks Therapeutics, Inc. Appoints Aaron Fox-Collis as Chief Accounting Officer and Principal Accounting Officer